RecruitingPhase 3NCT03678025
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Sponsor: SWOG Cancer Research Network
Albany, NY · Buffalo, NY · Dansville, NY · +331 more sites
Prostate Cancer clinical trials in Buffalo, NY
10 recruiting prostate cancer studies with a site in Buffalo, NY.
RecruitingPhase 2NCT06632977
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Sponsor: Alliance for Clinical Trials in Oncology
Buffalo, NY · New York, NY · +106 more sites
RecruitingPhase 3NCT07200830
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Sponsor: Alliance for Clinical Trials in Oncology
Buffalo, NY · Commack, NY · Harrison, NY · +135 more sites
RecruitingPhase 2NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Sponsor: Daiichi Sankyo
Buffalo, NY · New York, NY · +11 more sites
RecruitingPhase 1 / Phase 2NCT07181161
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
Sponsor: AstraZeneca
Buffalo, NY · New York, NY · +9 more sites
RecruitingPhase 1 / Phase 2NCT04104776
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Sponsor: Novartis Pharmaceuticals
Buffalo, NY · New York, NY · +19 more sites
RecruitingPhase not listedNCT03151629
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Sponsor: Prostate Cancer Clinical Trials Consortium
Brooklyn, NY · Buffalo, NY · +45 more sites
RecruitingPhase 4NCT06733350
Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance
Sponsor: Roswell Park Cancer Institute
Buffalo, NY
RecruitingNot applicableNCT06172283
Intermittent Fasting in Prostate Cancer Patients Receiving Androgen Deprivation Therapy
Sponsor: State University of New York at Buffalo
Buffalo, NY
RecruitingPhase 3NCT06563388
Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial
Sponsor: Roswell Park Cancer Institute
Buffalo, NY
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.